GlassScriptPhysician profile
Brittany Ewing O'Bryan
NPI 1093159303
$5,171.85
in general payments reported to CMS, 2019-2025
21 companies · $479 in 2025
The $479 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $40.17 · 2021: $19.00 · 2022: $420 · 2023: $3,181 · 2024: $708 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,684 · Food and Beverage: $1,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,684.42 |
| Food and Beverage | $1,682.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,199.32 | 2022-2025 | Ams 700, Tactra, Moses 550 D\F\L |
| Procept Biorobotics Corporation | $693.18 | 2023 | Aquabeam Robotic System |
| C. R. Bard, INC. & Subsidiaries | $296.31 | 2024-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Medtronic USA, INC. | $225.57 | 2019-2020 | |
| Davol INC. | $113.02 | 2022-2023 | Phasix Mesh |
| Medtronic, INC. | $104.20 | 2021-2024 | Interstim |
| Abbvie INC. | $99.66 | 2019-2025 | |
| Axonics, INC. | $71.18 | 2022-2024 | Bulkamid, Axonics |
| Rochester Medical Corporation | $50.42 | 2022 | |
| Pfizer INC. | $49.99 | 2020-2022 | |
| Astellas Pharma US INC | $39.65 | 2019 | |
| Janssen Biotech, INC. | $37.89 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $26.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.11 | 2023 | Lynparza |
| Olympus America INC. | $24.47 | 2025 | Soltive, Bovie, Olympus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $24.06 | 2019 | |
| Valencia Technologies Corporation | $23.80 | 2025 | Ecoin Device Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $20.87 | 2022 | |
| Endomagnetics LTD | $17.27 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.49 | 2023 | Prolaris |
| Polynovo North America LLC | $14.08 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany O'Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.